[1] LIU J, YAO L, ZHANG M, et al. Downregulation of LncRNA-XIST inhibited development of non-small cell lung cancer by activating miR-335/SOD2/ROS signal pathway mediated pyroptotic cell death[J]. Aging(Albany NY), 2019, 11(18): 7830.
[2] DONG Y, HUO X, SUN R, et al. lncRNA Gm15290 promotes cell proliferation and invasion in lung cancer through directly interacting with and suppressing the tumor suppressor miR-615-5p[J]. Biosci Rep, 2018, 38(5): 1.
[3] LI S, MEI Z, HU HB, et al. The lncRNA MALAT1 contributes to non-small cell lung cancer development via modulating miR-124/STAT3 axis[J]. J Cell Physiol, 2018, 233(9): 6679. doi: 10.1002/jcp.26325
[4] ZHANG YX, YUAN J, GAO ZM, et al. LncRNA TUC338 promotes invasion of lung cancer by activating MAPK pathway[J]. Eur Rev Med Pharmacol Sci, 2018, 22(2): 443.
[5] LI S, WU D, JIA H, et al. Long non-coding RNA LRRC75A-AS1 facilitates triple negative breast cancer cell proliferation and invasion via functioning as a ceRNA to modulate BAALC[J]. Cell Death Dis, 2020, 11(8): 643. doi: 10.1038/s41419-020-02821-2
[6] HE W, ZHANG Y, XIA S. LncRNA NNT‐AS1 promotes non‐small cell lung cancer progression through regulating miR-22-3p/YAP1 axis[J]. Thorac Cancer, 2020, 11(3): 549. doi: 10.1111/1759-7714.13280
[7] WEI S, WANG K, HUANG X, et al. LncRNA MALAT1 contributes to non-small cell lung cancer progression via modulating miR-200a-3p/programmed death-ligand 1 axis[J]. Int J Immunopathol Pharmacol, 2019, 33(1): 1.
[8] HE R, ZHANG FH, SHEN N. LncRNA FEZF1-AS1 enhances epithelial-mesenchymal transition(EMT) through suppressing E-cadherin and regulating WNT pathway in non-small cell lung cancer(NSCLC)[J]. Biomed Pharmacother, 2017, 95(1): 331.
[9] LU W, ZHANG H, NIU Y, et al. Long non-coding RNA linc00673 regulated non-small cell lung cancer proliferation, migration, invasion and epithelial mesenchymal transition by sponging miR-150-5p[J]. Mol Cancer, 2017, 16(1): 118. doi: 10.1186/s12943-017-0685-9
[10] CHEN QF, KONG JL, ZOU SC, et al. LncRNA LINC00342 regulated cell growth and metastasis in non-small cell lung cancer via targeting miR-203a-3p[J]. Eur Rev Med Pharmacol Sci, 2019, 23(17): 7408.
[11] CHEN J, LAN J, YE Z, et al. Long noncoding RNA LRRC75A-AS1 inhibits cell proliferation and migration in colorectal carcinoma[J]. Exp Biol Med(Maywood), 2019, 244(14): 1137. doi: 10.1177/1535370219874339
[12] WANG F, TIAN X, ZHOU J, et al. A three-lncRNA signature for prognosis prediction of acute myeloid leukemia in patients[J]. Mol Med Rep, 2018, 18(2): 1473.
[13] ZHANG L, LIU B. Sapylin inhibits lung cancer cell proliferation and promotes apoptosis by attenuating PI3K/AKT signaling[J]. J Cell Biochem, 2019, 120(9): 14679. doi: 10.1002/jcb.28729
[14] LIANG H, WANG C, GAO K, et al. MicroRNA 421 promotes the progression of non-small cell lung cancer by targeting HOPX and regulating the Wnt/β-catenin signaling pathway[J]. Mol Med Rep, 2019, 20(1): 151.
[15] SHA QK, CHEN L, XI JZ, et al. Long non-coding RNA LINC00858 promotes cells proliferation, migration and invasion by acting as a ceRNA of miR-22-3p in colorectal cancer[J]. Artif Cells Nanomed Biotechnol, 2019, 47(1): 1057. doi: 10.1080/21691401.2018.1544143
[16] DONG HX, WANG R, JIN XY, et al. LncRNA DGCR5 promotes lung adenocarcinoma(LUAD) progression via inhibiting hsa-mir-22-3p[J]. J Cell Physiol, 2018, 233(5): 4126. doi: 10.1002/jcp.26215
[17] WANG B, WANG K, JIN T, et al. NCK1-AS1 enhances glioma cell proliferation, radioresistance and chemoresistance via miR-22-3p/IGF1R ceRNA pathway[J]. Biomed Pharmacother, 2020, 129(1): 110395.
[18] GAN L, LV L, LIAO S. Long non coding RNA H19 regulates cell growth and metastasis via the miR-22-3p/Snail1 axis in gastric cancer[J]. Int J Oncol, 2019, 54(6): 2157.